Solesence, Inc. Common Stock (SLSN) - Total Assets
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) holds total assets worth $47.79 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Solesence, Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Solesence, Inc. Common Stock - Total Assets Trend (2021–2025)
This chart illustrates how Solesence, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. Check Solesence, Inc. Common Stock (SLSN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Solesence, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2025)
Solesence, Inc. Common Stock's total assets of $47.79 Million consist of 57.5% current assets and 42.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.6% |
| Accounts Receivable | $6.84 Million | 13.7% |
| Inventory | $18.51 Million | 37.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Solesence, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Solesence, Inc. Common Stock (SLSN) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Solesence, Inc. Common Stock's current assets represent 57.5% of total assets in 2025, an increase from 40.9% in 2021.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, up from 2.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 37.0% of total assets.
Solesence, Inc. Common Stock Competitors by Total Assets
Key competitors of Solesence, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
DR.Wu Skincare Co Ltd
TWO:6523
|
Taiwan | NT$1.59 Billion |
|
FN REPUBLIC Co. Ltd
KQ:064090
|
Korea | ₩76.50 Billion |
|
Mastrad
PA:ALMAS
|
France | €3.48 Million |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
|
Skin Elements Ltd
AU:SKN
|
Australia | AU$2.01 Million |
Solesence, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.08 | 1.09 | 1.05 |
| Quick Ratio | 0.70 | 0.43 | 0.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $13.72 Million | $3.03 Million | $713.00K |
Solesence, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Solesence, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.41 |
| Latest Market Cap to Assets Ratio | 1.81 |
| Asset Growth Rate (YoY) | 0.1% |
| Total Assets | $50.05 Million |
| Market Capitalization | $90.41 Million USD |
Valuation Analysis
Above Book Valuation: The market values Solesence, Inc. Common Stock's assets above their book value (1.81x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Solesence, Inc. Common Stock's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Solesence, Inc. Common Stock (2021–2025)
The table below shows the annual total assets of Solesence, Inc. Common Stock from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $50.05 Million | +0.11% |
| 2024-12-31 | $50.00 Million | +52.07% |
| 2023-12-31 | $32.88 Million | -2.02% |
| 2022-12-31 | $33.56 Million | +18.19% |
| 2021-12-31 | $28.39 Million | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingre… Read more